ReviewBritish journal of clinical pharmacology2025

Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective.

Amy Bobbins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.